Every indexed document

two Phase III trials in Lennox-Gastaut syndrome (LGS)

and Zynerba’s transdermal CBD gel ZYN002 in Fragile X syndrome.

and dosing strategy (single agent or in combination). Below we

pure CBD) was approved by the FDA in 2018

which gives the company access to one of the

Aurora acquired Uruguayan fully licensed ICC Labs Inc.

some CBD and some THC dominant. The company registered their seeds

and a framework for medical cannabis cultivation was established

the country has positioned itself for growth as demand for

there are not many hemp farms in the country.

and recently received a license to cultivate

Tilray entered a partnership with Alef Biotechnology (now Tilray Latin

this is practiced under “selfsupervision”

the Military Chemical and Pharmaceutical Plant (MCPP)

such as whole plant processing and financial support. Due

some CBD companies have expressed interest

and the number of kitchens and chefs using cannabisbased

CBD products have been widely available across the

as long as CBD products are not authorized by the MHRA

the number of patients who have been prescribed medical cannabis treatments